Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients

NCT01999881 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT01999881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01999881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
Lead sponsor
University of Wisconsin, Madison
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2013
Completion date
February 29, 2016
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

extensive stage small cell lung cancer, healthy, no evidence of disease, limited stage small cell lung cancer, recurrent non-small cell lung cancer, recurrent small cell lung cancer, stage ia non-small cell lung cancer, stage ib non-small cell lung cancer, stage iia non-small cell lung cancer, stage iib non-small cell lung cancer, stage iiia non-small cell lung cancer, stage iiib non-small cell lung cancer, stage iv non-small cell lung cancer